Oruka names Todd Edwards Chief Commercial Officer, eff. Aug 24 2026

Oruka Therapeutics, Inc.

Todd Edwards, ex-CCO of Arcutis Biotech, starts as Oruka's Chief Commercial Officer on Aug 24, 2026, reporting to CEO.
Annual base salary $525,000; target bonus 40% of base; $200,000 signing bonus repayable prorated if resignation within 1 year.
Equity grant: 20,000 options + 100,000 RSUs; options vest 25% at 1yr then monthly over 36mo, RSUs quarterly.
Severance: 12 months base salary outside CIC; within CIC 1.0x (base+target) plus full acceleration of time-based equity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.